PharmaSphere: US Healthcare Policy Update – Impact Analysis of the Affordable Care Act on Stakeholders
Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Anaylsis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
PharmaPoint: Hemophilia A and B Recombinant Factor Replacement Therapy – Global Drug Forecast and Market Analysis to 2024
Post-Transplant Lymphoproliferative Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players